The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Nemluvio Galderma Australia Pty Ltd
Product name
Nemluvio
Sponsor
Accepted date
May-2024
Active ingredients
nemolizumab
Proposed indication
For the treatment of moderate-to-severe atopic dermatitis.
Application type
A (new medicine)
Publication date
May-2024